Press release
December 2, 2025
ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors
ADARx Pharmaceuticals, Inc. (ADRX)
– Dr. Tagliaferri is a proven executive recognized for advancing innovative therapies across immunology, oncology and other serious diseases – SAN DIEGO, Calif. – December 2, 2025 – ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA